Researchers at the Stanford University School of Medicine have developed a way to quickly and efficiently convert human fat stem cells into liver cells.
Stanford University School of Medicine
A randomized, double-blind and placebo-controlled study involving Stanford University School of Medicine researchers showed that people with myelofibrosis – blood cancer – can benefit from ruxolitinib, the first FDA-approved therapy for myelofibrosis. Ruxolitinib blocks the JAK2 tyrosine kinase protein that is both mutated and unusually active in 50 to 60 percent of myelofibrosis patients.
Researchers at the Stanford University School of Medicine have shown that parts of the brain network that react to humor in an adult are already present in children ages six to 12. These neural circuits, while present in children, develop into more sophisticated networks as children mature, according to a statement on the School of Medicine’s website.
With flu season now underway, researchers at the Stanford University School of Medicine are exploring vaccines for influenza infection, commonly known as the flu, more than ever before.